NeuroAI NEUROAINEUROAI.SITE
ESC

AgiBot's US$2.1B Private Round Signals a Humanoid Capital Race

Shanghai humanoid maker AgiBot reached a ~US$2.1B private valuation in 2025 and is widely reported to be preparing a Hong Kong listing at a far higher mark.

2026-10-03 · 808 words · NeuroAI
AgiBot's US$2.1B Private Round Signals a Humanoid Capital Race

A Shanghai start-up built on a hardware hobbyist's fame is now the center of a funding contest. Its robots leave the factory faster than most rivals can ship a prototype. The real contest is no longer about engineering — it is about who owns the cap table before the public markets open.

From a famous builder to a funded company

AgiBot (智元机器人) was founded in February 2023 in Shanghai by Deng Taihua, a former Huawei computing-product-line president who became chairman and CEO, and Peng Zhihui — better known online as "Zhihuijun (稚晖君)" — a former Huawei "genius youth" engineer who serves as co-founder and CTO. The pairing of a corporate operator with a grassroots inventor gave the company instant credibility with both investors and engineers.

The product map spans three lines: the Yuanzheng (Expedition) A-series full-size humanoids for interaction and inspection, the smaller Lingxi (X) line for research and education, and the wheeled Genie (G) series aimed at factories and retail. That breadth lets AgiBot tell a "one body, many tasks" story rather than a single demo.

The Tencent round that reset the bar

In March 2025, AgiBot closed a Series B round led by Tencent, with a post-money valuation of about RMB 15 billion (≈ US$2.1 billion), according to multiple outlets including TMTPost and Chinese financial press. That was roughly double the ~RMB 7 billion mark cited less than a year earlier. JD.com later took a stake through its technology arm, and the Shanghai Embodied Intelligence Fund — a government-backed vehicle tied to the Pudong New Area — also invested.

The backer list reads like a roll call of Chinese strategic capital: Tencent, Sequoia China (HongShan), BYD, Hillhouse, JD.com and Baidu have all been named in filings and reports. For a company three years old, that is an unusually dense roster of deep-pocketed, operationally relevant owners.

Why the money moved

Investors are not buying a robot; they are buying a position in what many see as the next computing platform — the humanoid (人形机器人). Research firm Omdia has estimated AgiBot shipped roughly 5,000 humanoid units in 2025, placing it among the global leaders, and the company itself said it crossed 10,000 cumulative units in March 2026.

AgiBot's pitch is "full-stack": it builds the body, the motion control, the data factory that records robot behavior, and the embodied large model (大模型) that plans tasks. That vertical integration is exactly what late-stage capital rewards, because it removes dependence on outside suppliers and gives the company a defensible margin story.

The Hong Kong whisper

Through 2026, a steady drumbeat of reports placed AgiBot on a path to a Hong Kong IPO. Hong Kong's Economic Journal, citing mainland tech media, reported the company was seeking a listing at a valuation around US$20 billion (≈ HK$156 billion), had brought in CITIC Securities as sponsor, and expected full-year 2026 revenue near RMB 4 billion (≈ US$560 million). Those figures are reported, not filed, and should be read as ambition rather than commitment.

A backdoor that wasn't

In 2025, an AgiBot-linked holding platform took control of Swancor Advanced Materials (上纬新材, SH 688585), a STAR Market-listed chemicals firm. The move triggered speculation about a backdoor listing, but both sides publicly clarified it was not a shell transaction and that the two businesses would keep separate finances and operations. Still, it showed how aggressively the company is exploring capital-structure options short of a fresh IPO.

What the capital flow signals

Three things stand out for observers of China's AI money.

  • Strategic, not financial. BYD, Tencent and JD are buying into humanoids as a distribution and application play — fleets, logistics, retail — not just as a ticker.
  • A valuation re-rating is priced in. The gap between the 2025 private round (~US$2.1B) and the rumored IPO target (~US$20B) implies investors expect a step-change once the company shows scale and a cleaner financial story.
  • Hong Kong over Shanghai. A Hong Kong route signals a desire for international capital and a valuation benchmark less tied to A-share sentiment, a choice Unitree notably did not make.

Honest limitations

Valuations cited here come from disclosed rounds and media reports; not all are audited, and the IPO target is unconfirmed. Shipment and revenue figures mix company statements, analyst estimates (Omdia) and press leaks, so treat them as directional. The Swancor transaction and its "non-backdoor" framing rely on company clarifications and media accounts, not on full disclosure filings we reviewed. This is observatory analysis, not investment advice.

What readers can do now

  • Track AgiBot's filing status: a formal Hong Kong prospectus, if filed, is the only hard evidence of the rumored US$20B plan.
  • Watch independent analyst shipment numbers for the humanoid (人形机器人) category rather than marketing claims to judge whether the valuation is earned.
  • Compare AgiBot's path with Unitree's STAR Market debut to see which exchange and structure Chinese robot champions prefer.

Related coverage

More in “Capital & Markets” → · Back to home · Markdown version